View Valuation4Front Ventures 将来の成長Future 基準チェック /06現在、 4Front Venturesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Pharmaceuticals 収益成長14.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報お知らせ • May 264Front Ventures Corp. Reiterates Earnings Guidance for the Financial Year of 20214Front Ventures Corp. reiterated earnings guidance for the financial year of 2021. For the period the company expected guidance for Systemwide Pro Forma Revenue of $170 million to $180 million.お知らせ • Jul 314Front Ventures Corp. to Reopen Its Mission Dispensary in Chicago4Front Ventures Corp. announced that its Mission dispensary located in Chicago'sSouth Chicago neighborhood will re-open to patients and customers on July 31, 2020. The store was temporarily closed on May 31st as the result of looting in the wake of the recent protests and unrest in Chicago. As part of the reopening, Mission South Chicago will be holding a rededication rally at the store beginning on Friday July 31st at 9 a.m. CT featuring community members and local officials. Following the rally, Mission South Chicago will reopen its doors to patients and customers at 10 a.m. CT.すべての更新を表示Recent updatesお知らせ • Jun 274Front Ventures Corp. Announces Board Resignations, Effective June 26, 20254Front Ventures Corp. announced that Kris Krane, Chairman of the Board, and David Daily, Director, have tendered their resignations from the Company's Board of Directors effective June 26, 2025. Mr. Krane was both the Chair of the Board and a member of the Audit Committee; Mr. Daily was a director and Chair of the Audit Committee.お知らせ • Apr 044Front Ventures Corp. Announces Board Changes4Front Ventures Corp. announced changes to its Board of Directors, provided an update on the timing of its fourth quarter and fiscal year 2024 financial results, and announced the issuance of certain equity grants in lieu of cash Board pay. Effective March 29, 2025, Chetan Gulati, Roman Tkachenko, and Leo Gontmakher have stepped down from the Company's Board of Directors. These changes are part of a broader effort to enhance governance and support the Company's long-term strategic priorities. The departing directors are affiliated with the Company's senior lenders--Mr. Gulati with Navy Capital, and Messrs. Tkachenko and Gontmakher with LI Lending --and their resignations are intended to eliminate potential conflicts of interest and enable more independent oversight and decision making in regard to those lenders. Chairman Kris Krane and Audit Chair David Daily will remain on the Board to provide continuity.お知らせ • Apr 014Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2025, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Nov 084Front Ventures Corp. to Report Q3, 2024 Results on Nov 14, 20244Front Ventures Corp. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024お知らせ • Aug 074Front Ventures Corp. to Report Q2, 2024 Results on Aug 14, 20244Front Ventures Corp. announced that they will report Q2, 2024 results After-Market on Aug 14, 2024お知らせ • Jul 064Front Ventures Corp. Announces Management Changes4Front Ventures Corp. announced that current Company director Kris Krane became Chair of the Board in place of Robert Hunt, who is departing the Board. Mr. Krane has extensive experience in the cannabis industry, having previously served as the Company's President and played a key role in its growth and development. As a regulatory and business strategist, as well as a frequent speaker at cannabis conferences and events around the world, Mr. Krane has spent the last two decades working to advance the cannabis industry and movement. He has served as Associate Director of the National Organization for the Reform of Marijuana Laws ("NORML") and Executive Director of Students for Sensible Drug Policy, and is Chair Emeritus of the National Cannabis Industry Association Board of Directors. An Illinois resident, Krane's deep industry knowledge and local presence align with 4Front's strategic focus on growth in that state. Mr. Hunt's departure is not in connection with any known disagreement with the Company on any matter relating to the Company's operations, policies, or practices, including accounting principles and practices.お知らせ • May 16+ 1 more update4Front Ventures Corp. to Report Q1, 2024 Results on May 17, 20244Front Ventures Corp. announced that they will report Q1, 2024 results Pre-Market on May 17, 2024お知らせ • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 04/01/2024, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Mar 284Front Ventures Corp. to Report Q4, 2023 Results on Apr 15, 20244Front Ventures Corp. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Apr 15, 2024お知らせ • Jan 084Front Ventures Corp. Announces Chief Executive Officer Changes4Front Ventures Corp. announced that its board of directors have appointed Andrew Thut as Chief Executive Officer, effective January 8, 2024. Mr. Thut will succeed Leo Gontmakher, who has served as Chief Executive Officer since May 30, 2020. Mr. Gontmakher will remain on the Board as a director and serve as a consultant to the Company.お知らせ • Dec 124Front Ventures Corp. Debuts Cannabis Flower Brand the Hunt4Front Ventures Corp. announced the launch of cannabis flower brand, The Hunt, expanding the Company's brand portfolio in Massachusetts and adding to its growing offering of high quality, affordable flower. The Hunt's product lineup, which features exclusive offerings of rare, limited and small-batch phenotypes, is now available for purchase at 4Front's Mission Dispensaries in Georgetown, Worcester, and Brookline, MA, and at partner dispensaries across the Bay State. Each strain drop of The Hunt is only available for a limited time, while supplies last; the Company expects to introduce the new offering to Illinois cannabis consumers in first quarter 2024. Utilizing rare, heritage genetics, and creative cross breeding, The Hunt's unique and proprietary strains are available in small batches and limited releases. The latest release of The Hunt offers a lineup of indica dominant strains such as Mandarin Zkittles #4, Mandarin Zkittles #7, Mandarin Zkittles#10, Planet Sherb and Plasma Gas, as well as sativa dominant strains such as Crazey Hazey #5, Crazey Hazey #8, Killer Bees #1, and Killer Bees #6.お知らせ • Dec 014Front Ventures Corp. Announces Chief Financial Officer Changes4Front Ventures Corp. announced that effective November 30, 2023, Nicole Frederick resigned as Interim Chief Financial Officer to pursue another opportunity. Peter Kampian has been appointed Chief Financial Officer (CFO), effective December 1, 2023. Mr. Kampian, 64, will employ his wealth of experience in the financial sector to elevate the Company's finance and accounting functions. Kampian is a seasoned executive with over two decades of financial expertise gained through various roles, including his tenure as the Chief Financial Officer of Algonquin Power and Utilities Corp., where he led and supported debt and equity capital raising initiatives, along with numerous acquisitions. Kampian also held the role of CFO at Mettrum Health Corp., which was later acquired by Canopy Growth Corp., and serves as CFO at Electryon Power Inc. and Huxley Health Inc. In addition to his executive roles, Kampian has served on several boards, such as Aduro Clean Technologies Inc., Harborside Inc., Greenbutts Inc., Red Pine Exploration Inc., and as a director at Origin House. Most recently, he has applied his expertise as the Chief Restructuring Officer for the Canadian cannabis companies PharmHouse Inc. and Muskoka Grown Limited. He is a CPA and received a Bachelor of Business Administration from Wilfrid Laurier University.お知らせ • Nov 154Front Ventures Corp. announced delayed 10-Q filingOn 11/14/2023, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Nov 024Front Ventures Corp. to Report Q3, 2023 Results on Nov 14, 20234Front Ventures Corp. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023お知らせ • Oct 184Front Ventures Corp. announced that it expects to receive $10 million in funding4Front Ventures Corp. announced that it has entered into a $10 million senior secured credit facility agreement on October 16, 2023. The transaction will include participation from new lender, ALT Debt II, LP, managed by Altmore Capital Investment Management, LLC. The funds will be disbursed in two tranches. The credit facility will bear simple interest at a rate per annum equal to the greater of (i) the WSJ Prime Rate plus 7% and (ii) 15.5%, payable monthly and the maturity date of the credit facility will be September 30, 2026.お知らせ • Sep 154Front Ventures Broadens Illinois Offerings with Expansion of Island Cannabis Co. Product Line4Front Ventures Corp. announced the expansion of its product offerings in Illinois under its premium flower brand, Island Cannabis Co. ("Island"). The lineup features a new 7g size of Island's premium flower and the soon-to-be-released Island Classic Single Strain 1g Pre-Rolls, both offered in four distinct strains -- Garlic Z, Banana Puddintain, Grease Monkey, and Duct Tape. Customers can now find the Island 7g flower offering at 4Front's Mission dispensaries in Calumet City and South Chicago, with further expansion into partner dispensaries throughout the state planned for the coming weeks. As part of the launch, 4Front is proud to introduce the Island Adventure Pack promotion in celebration of National Public Lands Day on September 23(rd) . The country's largest single-day volunteer effort is organized by the National Environmental Education Foundation (NEEF) in partnership with the National Park Service, where Americans are encouraged to show their appreciation for the environment with free admission to over 400 National Parks. With the purchase of Island flower and Island Classic Single Strain Pre-Rolls, customers will receive an Island Cannabis Co. t-shirt, perfect for an adventure in Indiana Dunes National Park, located near 4Front's Mission dispensaries in Calumet City and South Chicago. Additionally, on September 30(th), Mission Dispensaries is sponsoring the Stand Up 2 Cancer comedy show at Signature Sports Bar and Grill, located at 3215 Union Ave, Steger, IL at 8:00 pm CT. The event is in support of Zero Prostate Cancer, a leading national nonprofit with a mission to end prostate cancer and help all who are impacted, with proceeds going toward veterans undergoing treatment. In support of the initiative, 4Front is offering attendees $10 off their next purchase of $65+ at Mission dispensaries in Calumet City and South Chicago. For more information on 4Front's charitable initiatives, visit the Company's website.お知らせ • Aug 064Front Ventures Corp. Announces Update to Senior Management TeamEffective July 31, 2023, Keith Adams resigned as Chief Financial Officer of 4Front Ventures Corp. Keith resigned to pursue other career opportunities. Effective immediately, the company has named Director of External Reporting, Nicole Frederick, age 31, to be interim Chief Financial Officer and have begun the process of identifying Keith's successor. Nicole has served as Director of External Reporting since August 2022. She began her career at EY, a big four accounting firm, in 2014. Prior to joining the Company, she held various roles in External Reporting at an infrastructure services company. Nicole is a CPA and holds a Master's and Bachelor's degree in Accountancy from Arizona State University, W. P. Carey School of Business.お知らせ • Aug 034Front Ventures Corp. to Report Q2, 2023 Results on Aug 15, 20234Front Ventures Corp. announced that they will report Q2, 2023 results After-Market on Aug 15, 2023New Risk • Jun 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$92.3m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Significant insider selling over the past 3 months (US$96k sold). Market cap is less than US$100m (US$92.3m market cap).お知らせ • Jun 074Front Ventures Corp., Annual General Meeting, Jul 14, 20234Front Ventures Corp., Annual General Meeting, Jul 14, 2023, at 12:00 US Eastern Standard Time. Location: 29 Everett Street Holliston Massachusetts United States Agenda: To consider and, if thought advisable, approve a resolution setting the number of directors for the present time at 6; to elect directors of the Company for the upcoming year; to appoint Davidson & Company LLP as the auditor of the Company for the upcoming year and to authorize the directors to fix their remuneration; to consider, and if thought fit, to pass, with or without variation, an ordinary resolution ratifying, confirming and approving the Company’s stock option plans and the unallocated options thereunder; and to consider other items of business that may be properly brought before the meeting.お知らせ • May 23Amit Patel Steps Down as a Director of 4Front Ventures Corp4Front Ventures Corp. announced that Amit Patel has stepped down as a director and the Chair of the Audit Committee of the Company, effective May 16, 2023.お知らせ • May 054Front Ventures Corp. Elevates the Cannabis Infused Chocolate Category4Front Ventures Corp. announced it is elevating the cannabis-infused chocolate category, premiering "Koko Gemz Variety Pack'' in Massachusetts. The new product offering features four chocolate flavors - Milk Chocolate, Dark Chocolate, Cookies & Cream and Peanut Butter Milk Chocolate - each made by the Company's master chocolatiers using handcrafted Belgian chocolates. Using only the highest quality ingredients, 4Front combined two things it loves most - chocolate and cannabis - to create a delectable assortment of vegetarian cannabis-infused treats in one convenient box. Each variety pack contains a mix of 20 Koko Gemz with 5mg of THC, delivering a tasty tension of chocolate, luscious smoothness and 100mg of THC in each box.お知らせ • Feb 104Front Ventures Corp. Debuts Cannabis Blunt Brand 1988, Expanding Product Suite4Front Ventures Corp. broadened its brand portfolio with the launch of 1988, a new line of flavored, tobacco-free blunts that feature the Company's top-tier flower. 1988 is now available at 4Front's Mission Dispensaries in Georgetown, Worcester and Brookline, Massachusetts. The new brand will continue to roll out to partner dispensaries in the Bay State and to Illinois cannabis consumers later this year. The 1988 pre-rolled 1 gram blunts are packed full of 4Front's choice nugs, rolled into tobacco-free blunt cones and are available as singles in dube tubes. The filterless, slow-burning blunts are available in a variety of strains and flavors designed to enhance the strain's flavor profile and user experience.お知らせ • May 264Front Ventures Corp. Reiterates Earnings Guidance for the Financial Year of 20214Front Ventures Corp. reiterated earnings guidance for the financial year of 2021. For the period the company expected guidance for Systemwide Pro Forma Revenue of $170 million to $180 million.お知らせ • May 194Front Ventures Corp. announced delayed 10-Q filingOn 05/18/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.お知らせ • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.お知らせ • Feb 094Front Ventures Corp. Announces Resignation of Nicolle Dorsey, Chief Financial OfficerOn February 1, 2021, Nicolle Dorsey ceased serving as the Chief Financial Officer of 4Front Ventures Corp. (the “Company”). On February 3, 2021, the Company and Ms. Dorsey entered into a separation agreement (the “Separation Agreement”), under which she will continue to provide services to the Company in a temporary support role.お知らせ • Jan 284Front Ventures Receives Approval to Begin Construction of Mission Dispensary in Brookline, Massachusetts4Front Ventures Corp. announced that it received approval from the Brookline, Massachusetts Planning Board to start the construction of a new Mission branded dispensary. The location will initially serve adult-use customers and is on track to open in second quarter 2021. 4Front's new dispensary will be located at 1024 Commonwealth Avenue in Brookline, with the storefront opening to Boston proper. The location will serve the Brookline, Allston corridor, a vibrant community within the wider Boston University and Boston metropolitan area. Mission Brookline will carry a full line of 4Front's high-quality, adult-use cannabis brands and products, including flower, extracts, edibles, and vapes. Mission's expertly trained staff will be available to ensure an informative, welcoming, and inclusive experience for all consumers. Adult-use customers will be able to browse live inventory, place online orders and pickup orders in-store.お知らせ • Nov 244Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million.4Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 21,430,000 Price\Range: CAD 0.7 Discount Per Security: CAD 0.042 Transaction Features: Regulation S; Rule 144Aお知らせ • Nov 204Front Ventures Corp. to Report Q3, 2020 Results on Nov 30, 20204Front Ventures Corp. announced that they will report Q3, 2020 results on Nov 30, 2020お知らせ • Sep 26Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million.Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. As of September 23, 2020, Ethos Cannabis completed the acquisition of three Maryland dispensaries for approximately $5.5 million. Beacon Securities Limited acted as financial advisor to 4Front Ventures.お知らせ • Sep 24Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT).Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. Beacon Securities Limited acted as financial advisor to 4Front Ventures. Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT) on September 23, 2020.お知らせ • Aug 284Front Ventures Corp. to Report Q2, 2020 Results on Aug 31, 20204Front Ventures Corp. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 31, 2020お知らせ • Jul 314Front Ventures Corp. to Reopen Its Mission Dispensary in Chicago4Front Ventures Corp. announced that its Mission dispensary located in Chicago'sSouth Chicago neighborhood will re-open to patients and customers on July 31, 2020. The store was temporarily closed on May 31st as the result of looting in the wake of the recent protests and unrest in Chicago. As part of the reopening, Mission South Chicago will be holding a rededication rally at the store beginning on Friday July 31st at 9 a.m. CT featuring community members and local officials. Following the rally, Mission South Chicago will reopen its doors to patients and customers at 10 a.m. CT.お知らせ • Jul 184Front Ventures Corp. to Report Q1, 2020 Results on Jul 14, 20204Front Ventures Corp. announced that they will report Q1, 2020 results at 5:00 PM, Eastern Standard Time on Jul 14, 2020お知らせ • Jul 104Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission.4Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission on July 9, 2020.お知らせ • Jun 20An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.お知らせ • Jun 19An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.お知らせ • Jun 17+ 3 more updatesAn unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、4Front Ventures は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:FFNT.F - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数9/30/202476-3505N/A6/30/202481-5506N/A3/31/202490-5527N/A12/31/202397-45-5-2N/A9/30/2023104-5177N/A6/30/2023109-2988N/A3/31/2023108-2345N/A12/31/2022108-2189N/A9/30/2022108-26-20N/A6/30/2022106-27-5-1N/A3/31/2022108-33-71N/A12/31/2021105-38-86N/A9/30/202193-54-39-24N/A6/30/202182-58-35-16N/A3/31/202168-62-25-8N/A12/31/202058-60-28-14N/A9/30/202050-185-137N/A6/30/202040-187-31-10N/A3/31/202030-183-50-26N/A12/31/201919-179-48-27N/A9/30/201913-23-47-27N/A6/30/20198-14-33-20N/A3/31/20196-12-27-16N/A12/31/20184-9-23-13N/A9/30/20181-9-12-8N/A12/31/20171-4N/A-4N/A12/31/20162-5N/A-8N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: FFNT.Fの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: FFNT.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: FFNT.Fの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: FFNT.Fの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: FFNT.Fの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: FFNT.Fの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YPharmaceuticals-biotech 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 18:49終値2026/05/18 00:00収益2024/09/30年間収益2023/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋4Front Ventures Corp. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。2 アナリスト機関Jonathan DeCourceyBTIGMatt BottomleyCanaccord Genuity
お知らせ • May 264Front Ventures Corp. Reiterates Earnings Guidance for the Financial Year of 20214Front Ventures Corp. reiterated earnings guidance for the financial year of 2021. For the period the company expected guidance for Systemwide Pro Forma Revenue of $170 million to $180 million.
お知らせ • Jul 314Front Ventures Corp. to Reopen Its Mission Dispensary in Chicago4Front Ventures Corp. announced that its Mission dispensary located in Chicago'sSouth Chicago neighborhood will re-open to patients and customers on July 31, 2020. The store was temporarily closed on May 31st as the result of looting in the wake of the recent protests and unrest in Chicago. As part of the reopening, Mission South Chicago will be holding a rededication rally at the store beginning on Friday July 31st at 9 a.m. CT featuring community members and local officials. Following the rally, Mission South Chicago will reopen its doors to patients and customers at 10 a.m. CT.
お知らせ • Jun 274Front Ventures Corp. Announces Board Resignations, Effective June 26, 20254Front Ventures Corp. announced that Kris Krane, Chairman of the Board, and David Daily, Director, have tendered their resignations from the Company's Board of Directors effective June 26, 2025. Mr. Krane was both the Chair of the Board and a member of the Audit Committee; Mr. Daily was a director and Chair of the Audit Committee.
お知らせ • Apr 044Front Ventures Corp. Announces Board Changes4Front Ventures Corp. announced changes to its Board of Directors, provided an update on the timing of its fourth quarter and fiscal year 2024 financial results, and announced the issuance of certain equity grants in lieu of cash Board pay. Effective March 29, 2025, Chetan Gulati, Roman Tkachenko, and Leo Gontmakher have stepped down from the Company's Board of Directors. These changes are part of a broader effort to enhance governance and support the Company's long-term strategic priorities. The departing directors are affiliated with the Company's senior lenders--Mr. Gulati with Navy Capital, and Messrs. Tkachenko and Gontmakher with LI Lending --and their resignations are intended to eliminate potential conflicts of interest and enable more independent oversight and decision making in regard to those lenders. Chairman Kris Krane and Audit Chair David Daily will remain on the Board to provide continuity.
お知らせ • Apr 014Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2025, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Nov 084Front Ventures Corp. to Report Q3, 2024 Results on Nov 14, 20244Front Ventures Corp. announced that they will report Q3, 2024 results After-Market on Nov 14, 2024
お知らせ • Aug 074Front Ventures Corp. to Report Q2, 2024 Results on Aug 14, 20244Front Ventures Corp. announced that they will report Q2, 2024 results After-Market on Aug 14, 2024
お知らせ • Jul 064Front Ventures Corp. Announces Management Changes4Front Ventures Corp. announced that current Company director Kris Krane became Chair of the Board in place of Robert Hunt, who is departing the Board. Mr. Krane has extensive experience in the cannabis industry, having previously served as the Company's President and played a key role in its growth and development. As a regulatory and business strategist, as well as a frequent speaker at cannabis conferences and events around the world, Mr. Krane has spent the last two decades working to advance the cannabis industry and movement. He has served as Associate Director of the National Organization for the Reform of Marijuana Laws ("NORML") and Executive Director of Students for Sensible Drug Policy, and is Chair Emeritus of the National Cannabis Industry Association Board of Directors. An Illinois resident, Krane's deep industry knowledge and local presence align with 4Front's strategic focus on growth in that state. Mr. Hunt's departure is not in connection with any known disagreement with the Company on any matter relating to the Company's operations, policies, or practices, including accounting principles and practices.
お知らせ • May 16+ 1 more update4Front Ventures Corp. to Report Q1, 2024 Results on May 17, 20244Front Ventures Corp. announced that they will report Q1, 2024 results Pre-Market on May 17, 2024
お知らせ • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 04/01/2024, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Mar 284Front Ventures Corp. to Report Q4, 2023 Results on Apr 15, 20244Front Ventures Corp. announced that they will report Q4, 2023 results at 4:00 PM, US Eastern Standard Time on Apr 15, 2024
お知らせ • Jan 084Front Ventures Corp. Announces Chief Executive Officer Changes4Front Ventures Corp. announced that its board of directors have appointed Andrew Thut as Chief Executive Officer, effective January 8, 2024. Mr. Thut will succeed Leo Gontmakher, who has served as Chief Executive Officer since May 30, 2020. Mr. Gontmakher will remain on the Board as a director and serve as a consultant to the Company.
お知らせ • Dec 124Front Ventures Corp. Debuts Cannabis Flower Brand the Hunt4Front Ventures Corp. announced the launch of cannabis flower brand, The Hunt, expanding the Company's brand portfolio in Massachusetts and adding to its growing offering of high quality, affordable flower. The Hunt's product lineup, which features exclusive offerings of rare, limited and small-batch phenotypes, is now available for purchase at 4Front's Mission Dispensaries in Georgetown, Worcester, and Brookline, MA, and at partner dispensaries across the Bay State. Each strain drop of The Hunt is only available for a limited time, while supplies last; the Company expects to introduce the new offering to Illinois cannabis consumers in first quarter 2024. Utilizing rare, heritage genetics, and creative cross breeding, The Hunt's unique and proprietary strains are available in small batches and limited releases. The latest release of The Hunt offers a lineup of indica dominant strains such as Mandarin Zkittles #4, Mandarin Zkittles #7, Mandarin Zkittles#10, Planet Sherb and Plasma Gas, as well as sativa dominant strains such as Crazey Hazey #5, Crazey Hazey #8, Killer Bees #1, and Killer Bees #6.
お知らせ • Dec 014Front Ventures Corp. Announces Chief Financial Officer Changes4Front Ventures Corp. announced that effective November 30, 2023, Nicole Frederick resigned as Interim Chief Financial Officer to pursue another opportunity. Peter Kampian has been appointed Chief Financial Officer (CFO), effective December 1, 2023. Mr. Kampian, 64, will employ his wealth of experience in the financial sector to elevate the Company's finance and accounting functions. Kampian is a seasoned executive with over two decades of financial expertise gained through various roles, including his tenure as the Chief Financial Officer of Algonquin Power and Utilities Corp., where he led and supported debt and equity capital raising initiatives, along with numerous acquisitions. Kampian also held the role of CFO at Mettrum Health Corp., which was later acquired by Canopy Growth Corp., and serves as CFO at Electryon Power Inc. and Huxley Health Inc. In addition to his executive roles, Kampian has served on several boards, such as Aduro Clean Technologies Inc., Harborside Inc., Greenbutts Inc., Red Pine Exploration Inc., and as a director at Origin House. Most recently, he has applied his expertise as the Chief Restructuring Officer for the Canadian cannabis companies PharmHouse Inc. and Muskoka Grown Limited. He is a CPA and received a Bachelor of Business Administration from Wilfrid Laurier University.
お知らせ • Nov 154Front Ventures Corp. announced delayed 10-Q filingOn 11/14/2023, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Nov 024Front Ventures Corp. to Report Q3, 2023 Results on Nov 14, 20234Front Ventures Corp. announced that they will report Q3, 2023 results After-Market on Nov 14, 2023
お知らせ • Oct 184Front Ventures Corp. announced that it expects to receive $10 million in funding4Front Ventures Corp. announced that it has entered into a $10 million senior secured credit facility agreement on October 16, 2023. The transaction will include participation from new lender, ALT Debt II, LP, managed by Altmore Capital Investment Management, LLC. The funds will be disbursed in two tranches. The credit facility will bear simple interest at a rate per annum equal to the greater of (i) the WSJ Prime Rate plus 7% and (ii) 15.5%, payable monthly and the maturity date of the credit facility will be September 30, 2026.
お知らせ • Sep 154Front Ventures Broadens Illinois Offerings with Expansion of Island Cannabis Co. Product Line4Front Ventures Corp. announced the expansion of its product offerings in Illinois under its premium flower brand, Island Cannabis Co. ("Island"). The lineup features a new 7g size of Island's premium flower and the soon-to-be-released Island Classic Single Strain 1g Pre-Rolls, both offered in four distinct strains -- Garlic Z, Banana Puddintain, Grease Monkey, and Duct Tape. Customers can now find the Island 7g flower offering at 4Front's Mission dispensaries in Calumet City and South Chicago, with further expansion into partner dispensaries throughout the state planned for the coming weeks. As part of the launch, 4Front is proud to introduce the Island Adventure Pack promotion in celebration of National Public Lands Day on September 23(rd) . The country's largest single-day volunteer effort is organized by the National Environmental Education Foundation (NEEF) in partnership with the National Park Service, where Americans are encouraged to show their appreciation for the environment with free admission to over 400 National Parks. With the purchase of Island flower and Island Classic Single Strain Pre-Rolls, customers will receive an Island Cannabis Co. t-shirt, perfect for an adventure in Indiana Dunes National Park, located near 4Front's Mission dispensaries in Calumet City and South Chicago. Additionally, on September 30(th), Mission Dispensaries is sponsoring the Stand Up 2 Cancer comedy show at Signature Sports Bar and Grill, located at 3215 Union Ave, Steger, IL at 8:00 pm CT. The event is in support of Zero Prostate Cancer, a leading national nonprofit with a mission to end prostate cancer and help all who are impacted, with proceeds going toward veterans undergoing treatment. In support of the initiative, 4Front is offering attendees $10 off their next purchase of $65+ at Mission dispensaries in Calumet City and South Chicago. For more information on 4Front's charitable initiatives, visit the Company's website.
お知らせ • Aug 064Front Ventures Corp. Announces Update to Senior Management TeamEffective July 31, 2023, Keith Adams resigned as Chief Financial Officer of 4Front Ventures Corp. Keith resigned to pursue other career opportunities. Effective immediately, the company has named Director of External Reporting, Nicole Frederick, age 31, to be interim Chief Financial Officer and have begun the process of identifying Keith's successor. Nicole has served as Director of External Reporting since August 2022. She began her career at EY, a big four accounting firm, in 2014. Prior to joining the Company, she held various roles in External Reporting at an infrastructure services company. Nicole is a CPA and holds a Master's and Bachelor's degree in Accountancy from Arizona State University, W. P. Carey School of Business.
お知らせ • Aug 034Front Ventures Corp. to Report Q2, 2023 Results on Aug 15, 20234Front Ventures Corp. announced that they will report Q2, 2023 results After-Market on Aug 15, 2023
New Risk • Jun 08New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: US$92.3m This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (11% average weekly change). Significant insider selling over the past 3 months (US$96k sold). Market cap is less than US$100m (US$92.3m market cap).
お知らせ • Jun 074Front Ventures Corp., Annual General Meeting, Jul 14, 20234Front Ventures Corp., Annual General Meeting, Jul 14, 2023, at 12:00 US Eastern Standard Time. Location: 29 Everett Street Holliston Massachusetts United States Agenda: To consider and, if thought advisable, approve a resolution setting the number of directors for the present time at 6; to elect directors of the Company for the upcoming year; to appoint Davidson & Company LLP as the auditor of the Company for the upcoming year and to authorize the directors to fix their remuneration; to consider, and if thought fit, to pass, with or without variation, an ordinary resolution ratifying, confirming and approving the Company’s stock option plans and the unallocated options thereunder; and to consider other items of business that may be properly brought before the meeting.
お知らせ • May 23Amit Patel Steps Down as a Director of 4Front Ventures Corp4Front Ventures Corp. announced that Amit Patel has stepped down as a director and the Chair of the Audit Committee of the Company, effective May 16, 2023.
お知らせ • May 054Front Ventures Corp. Elevates the Cannabis Infused Chocolate Category4Front Ventures Corp. announced it is elevating the cannabis-infused chocolate category, premiering "Koko Gemz Variety Pack'' in Massachusetts. The new product offering features four chocolate flavors - Milk Chocolate, Dark Chocolate, Cookies & Cream and Peanut Butter Milk Chocolate - each made by the Company's master chocolatiers using handcrafted Belgian chocolates. Using only the highest quality ingredients, 4Front combined two things it loves most - chocolate and cannabis - to create a delectable assortment of vegetarian cannabis-infused treats in one convenient box. Each variety pack contains a mix of 20 Koko Gemz with 5mg of THC, delivering a tasty tension of chocolate, luscious smoothness and 100mg of THC in each box.
お知らせ • Feb 104Front Ventures Corp. Debuts Cannabis Blunt Brand 1988, Expanding Product Suite4Front Ventures Corp. broadened its brand portfolio with the launch of 1988, a new line of flavored, tobacco-free blunts that feature the Company's top-tier flower. 1988 is now available at 4Front's Mission Dispensaries in Georgetown, Worcester and Brookline, Massachusetts. The new brand will continue to roll out to partner dispensaries in the Bay State and to Illinois cannabis consumers later this year. The 1988 pre-rolled 1 gram blunts are packed full of 4Front's choice nugs, rolled into tobacco-free blunt cones and are available as singles in dube tubes. The filterless, slow-burning blunts are available in a variety of strains and flavors designed to enhance the strain's flavor profile and user experience.
お知らせ • May 264Front Ventures Corp. Reiterates Earnings Guidance for the Financial Year of 20214Front Ventures Corp. reiterated earnings guidance for the financial year of 2021. For the period the company expected guidance for Systemwide Pro Forma Revenue of $170 million to $180 million.
お知らせ • May 194Front Ventures Corp. announced delayed 10-Q filingOn 05/18/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.
お知らせ • Apr 024Front Ventures Corp. announced delayed annual 10-K filingOn 03/31/2021, 4Front Ventures Corp. announced that they will be unable to file their next 10-K by the deadline required by the SEC.
お知らせ • Feb 094Front Ventures Corp. Announces Resignation of Nicolle Dorsey, Chief Financial OfficerOn February 1, 2021, Nicolle Dorsey ceased serving as the Chief Financial Officer of 4Front Ventures Corp. (the “Company”). On February 3, 2021, the Company and Ms. Dorsey entered into a separation agreement (the “Separation Agreement”), under which she will continue to provide services to the Company in a temporary support role.
お知らせ • Jan 284Front Ventures Receives Approval to Begin Construction of Mission Dispensary in Brookline, Massachusetts4Front Ventures Corp. announced that it received approval from the Brookline, Massachusetts Planning Board to start the construction of a new Mission branded dispensary. The location will initially serve adult-use customers and is on track to open in second quarter 2021. 4Front's new dispensary will be located at 1024 Commonwealth Avenue in Brookline, with the storefront opening to Boston proper. The location will serve the Brookline, Allston corridor, a vibrant community within the wider Boston University and Boston metropolitan area. Mission Brookline will carry a full line of 4Front's high-quality, adult-use cannabis brands and products, including flower, extracts, edibles, and vapes. Mission's expertly trained staff will be available to ensure an informative, welcoming, and inclusive experience for all consumers. Adult-use customers will be able to browse live inventory, place online orders and pickup orders in-store.
お知らせ • Nov 244Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million.4Front Ventures Corp. has completed a Composite Units Offering in the amount of CAD 15.001 million. Security Name: Units Security Type: Equity/Derivative Unit Securities Offered: 21,430,000 Price\Range: CAD 0.7 Discount Per Security: CAD 0.042 Transaction Features: Regulation S; Rule 144A
お知らせ • Nov 204Front Ventures Corp. to Report Q3, 2020 Results on Nov 30, 20204Front Ventures Corp. announced that they will report Q3, 2020 results on Nov 30, 2020
お知らせ • Sep 26Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million.Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. As of September 23, 2020, Ethos Cannabis completed the acquisition of three Maryland dispensaries for approximately $5.5 million. Beacon Securities Limited acted as financial advisor to 4Front Ventures.
お知らせ • Sep 24Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT).Ethos Cannabis entered into a definitive agreement to acquire Dispensaries in Pennsylvania And Maryland from 4Front Ventures Corp. (CNSX:FFNT) for approximately $18 million on May 1, 2020. Ethos will take over one operational Mission-branded dispensary location in Allentown, Pennsylvania, as well as four more in Maryland. The four operational locations in Maryland are located in Catonsville, Hampden, Glenmont and Rockville. Initially, Ethos will operate its Maryland locations via a management agreement. In time, it will acquire the equity once regulatory periods close. All Mission-branded dispensaries will be renamed under the Ethos brand. The transaction is subject to regulatory approval from authorities in both Pennsylvania and Maryland. As of May 15, 2020, Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania for approximately $10.6 million in cash. Acquisition of Dispensaries in Maryland is subject to pending certain regulatory approvals and expected to close over the next 45 days. As of August 31, 2020, the closing of Maryland divestitures is expected to be completed in early September. The majority of the proceeds from the transaction are expected to be received in the next week, with the remainder closing over the next 45 days. As of September 23, 2020, transaction has received pending final regulatory approval from the Maryland Medical Cannabis Commission. Upon receipt of proceeds from the transaction, 4Front anticipates prepaying up to $10 million of its outstanding debt obligations to entities associated with Gotham Green Partners. Beacon Securities Limited acted as financial advisor to 4Front Ventures. Ethos Cannabis completed the acquisition of Dispensaries in Pennsylvania and Maryland of 4Front Ventures Corp. (CNSX:FFNT) on September 23, 2020.
お知らせ • Aug 284Front Ventures Corp. to Report Q2, 2020 Results on Aug 31, 20204Front Ventures Corp. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 31, 2020
お知らせ • Jul 314Front Ventures Corp. to Reopen Its Mission Dispensary in Chicago4Front Ventures Corp. announced that its Mission dispensary located in Chicago'sSouth Chicago neighborhood will re-open to patients and customers on July 31, 2020. The store was temporarily closed on May 31st as the result of looting in the wake of the recent protests and unrest in Chicago. As part of the reopening, Mission South Chicago will be holding a rededication rally at the store beginning on Friday July 31st at 9 a.m. CT featuring community members and local officials. Following the rally, Mission South Chicago will reopen its doors to patients and customers at 10 a.m. CT.
お知らせ • Jul 184Front Ventures Corp. to Report Q1, 2020 Results on Jul 14, 20204Front Ventures Corp. announced that they will report Q1, 2020 results at 5:00 PM, Eastern Standard Time on Jul 14, 2020
お知らせ • Jul 104Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission.4Front Ventures Corp. (CNSX:FFNT) entered into an agreement to acquire Georgetown Mission facility from Massachusetts Cannabis Control Commission on July 9, 2020.
お知らせ • Jun 20An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Arkansas Patient Services Company Group Management LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.
お知らせ • Jun 19An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired Mission Pennsylvania II LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.
お知らせ • Jun 17+ 3 more updatesAn unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT).An unknown buyer acquired 80% stake in Premium Medicine of Maryland LLC from 4Front Ventures Corp. (CNSX:FFNT) subsequent to December 31, 2019.